Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |